▶ 調査レポート

がん治療ワクチンの世界市場 2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Therapeutic Cancer Vaccines Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。がん治療ワクチンの世界市場 2020年:メーカー別、地域別、種類・用途別 / Global Therapeutic Cancer Vaccines Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / D0804-13101資料のイメージです。• レポートコード:D0804-13101
• 出版社/出版日:GlobalInfoResearch / 2020年8月
• レポート形態:英文、PDF、104ページ
• 納品方法:Eメール(納期2~3日)
• 産業分類:医薬品・治療
• 販売価格(消費税別)
  Single User¥372,360 (USD3,480)▷ お問い合わせ
  Multi User¥558,540 (USD5,220)▷ お問い合わせ
  Corporate User¥744,720 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、がん治療ワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。がん治療ワクチンの種類別市場規模(全細胞ワクチン、抗原ワクチン、非特異的・サイトカイン戦略、その他)、用途別市場規模(膀胱がん、脳腫瘍、乳がん、肺がん、前立腺がん、子宮頸がん、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Antigenics、Moderna、Bayer、Asterias Biotherapeutics、Merck、Avax Technologies、VAXIMM、Mayo Clinic、GlaxoSmithKline、Northwest Biotherapeutics
・地域別グローバル市場分析 2015年-2020年
・がん治療ワクチンの北米市場(アメリカ、カナダ、メキシコ)
・がん治療ワクチンのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・がん治療ワクチンのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・がん治療ワクチンの南米市場(ブラジル、アルゼンチン)
・がん治療ワクチンの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:全細胞ワクチン、抗原ワクチン、非特異的・サイトカイン戦略、その他
・用途別分析:膀胱がん、脳腫瘍、乳がん、肺がん、前立腺がん、子宮頸がん、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The Therapeutic Cancer Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Therapeutic Cancer Vaccines sales will be xx in 2020 from Therapeutic Cancer Vaccines million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Therapeutic Cancer Vaccines market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Therapeutic Cancer Vaccines industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Therapeutic Cancer Vaccines and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
Therapeutic Cancer Vaccines market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Therapeutic Cancer Vaccines market has been segmented into
Whole Cell Vaccine
Antigen Vaccine
Non-specific and Cytokine Strategies
Others

By Application, Therapeutic Cancer Vaccines has been segmented into:
Bladder Cancer
Brain Tumors
Breast Cancer
Lung Cancer
Prostate Cancer
Cervical Cancer
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Therapeutic Cancer Vaccines market presented in the report. This section sheds light on the sales growth of different regional and country-level Therapeutic Cancer Vaccines markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Therapeutic Cancer Vaccines market.

The report offers in-depth assessment of the growth and other aspects of the Therapeutic Cancer Vaccines market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Therapeutic Cancer Vaccines Market Share Analysis
Therapeutic Cancer Vaccines competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Therapeutic Cancer Vaccines sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Therapeutic Cancer Vaccines sales, revenue and market share for each player covered in this report.

The major players covered in Therapeutic Cancer Vaccines are:
Antigenics
Moderna
Bayer
Asterias Biotherapeutics
Merck
Avax Technologies
VAXIMM
Mayo Clinic
GlaxoSmithKline
Northwest Biotherapeutics

Among other players domestic and global, Therapeutic Cancer Vaccines market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Therapeutic Cancer Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Therapeutic Cancer Vaccines, with price, sales, revenue and global market share of Therapeutic Cancer Vaccines in 2018 and 2019.
Chapter 3, the Therapeutic Cancer Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Therapeutic Cancer Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Therapeutic Cancer Vaccines market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Therapeutic Cancer Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Therapeutic Cancer Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Therapeutic Cancer Vaccines Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Whole Cell Vaccine
1.2.3 Antigen Vaccine
1.2.4 Non-specific and Cytokine Strategies
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Therapeutic Cancer Vaccines Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Bladder Cancer
1.3.3 Brain Tumors
1.3.4 Breast Cancer
1.3.5 Lung Cancer
1.3.6 Prostate Cancer
1.3.7 Cervical Cancer
1.3.8 Others
1.4 Overview of Global Therapeutic Cancer Vaccines Market
1.4.1 Global Therapeutic Cancer Vaccines Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Therapeutic Cancer Vaccines Industry Impact
1.6.1 COVID-19 Potential Implications for the Therapeutic Cancer Vaccines
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Therapeutic Cancer Vaccines
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 Antigenics
2.1.1 Antigenics Details
2.1.2 Antigenics Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Antigenics SWOT Analysis
2.1.4 Antigenics Product and Services
2.1.5 Antigenics Therapeutic Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Moderna
2.2.1 Moderna Details
2.2.2 Moderna Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Moderna SWOT Analysis
2.2.4 Moderna Product and Services
2.2.5 Moderna Therapeutic Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bayer SWOT Analysis
2.3.4 Bayer Product and Services
2.3.5 Bayer Therapeutic Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Asterias Biotherapeutics
2.4.1 Asterias Biotherapeutics Details
2.4.2 Asterias Biotherapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Asterias Biotherapeutics SWOT Analysis
2.4.4 Asterias Biotherapeutics Product and Services
2.4.5 Asterias Biotherapeutics Therapeutic Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Merck SWOT Analysis
2.5.4 Merck Product and Services
2.5.5 Merck Therapeutic Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Avax Technologies
2.6.1 Avax Technologies Details
2.6.2 Avax Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Avax Technologies SWOT Analysis
2.6.4 Avax Technologies Product and Services
2.6.5 Avax Technologies Therapeutic Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 VAXIMM
2.7.1 VAXIMM Details
2.7.2 VAXIMM Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 VAXIMM SWOT Analysis
2.7.4 VAXIMM Product and Services
2.7.5 VAXIMM Therapeutic Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Mayo Clinic
2.8.1 Mayo Clinic Details
2.8.2 Mayo Clinic Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Mayo Clinic SWOT Analysis
2.8.4 Mayo Clinic Product and Services
2.8.5 Mayo Clinic Therapeutic Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 GlaxoSmithKline
2.9.1 GlaxoSmithKline Details
2.9.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 GlaxoSmithKline SWOT Analysis
2.9.4 GlaxoSmithKline Product and Services
2.9.5 GlaxoSmithKline Therapeutic Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Northwest Biotherapeutics
2.10.1 Northwest Biotherapeutics Details
2.10.2 Northwest Biotherapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Northwest Biotherapeutics SWOT Analysis
2.10.4 Northwest Biotherapeutics Product and Services
2.10.5 Northwest Biotherapeutics Therapeutic Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Therapeutic Cancer Vaccines Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Therapeutic Cancer Vaccines Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Therapeutic Cancer Vaccines Manufacturer Market Share in 2019
3.3.2 Top 6 Therapeutic Cancer Vaccines Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Therapeutic Cancer Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global Therapeutic Cancer Vaccines Sales and Market Share by Regions (2015-2020)
4.1.2 Global Therapeutic Cancer Vaccines Revenue and Market Share by Regions (2015-2020)
4.2 North America Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020)
4.3 Europe Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020)
4.5 South America Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Therapeutic Cancer Vaccines Sales, Revenue and Market Share by Country
5.1.1 North America Therapeutic Cancer Vaccines Sales and Market Share by Country (2015-2020)
5.1.2 North America Therapeutic Cancer Vaccines Revenue and Market Share by Country (2015-2020)
5.2 United States Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020)
5.3 Canada Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020)
5.4 Mexico Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Therapeutic Cancer Vaccines Sales, Revenue and Market Share by Country
6.1.1 Europe Therapeutic Cancer Vaccines Sales and Market Share by Country (2015-2020)
6.1.2 Europe Therapeutic Cancer Vaccines Revenue and Market Share by Country (2015-2020)
6.2 Germany Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020)
6.3 UK Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020)
6.4 France Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020)
6.5 Russia Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020)
6.6 Italy Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Therapeutic Cancer Vaccines Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Therapeutic Cancer Vaccines Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Therapeutic Cancer Vaccines Revenue and Market Share by Regions (2015-2020)
7.2 China Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020)
7.3 Japan Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020)
7.4 Korea Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020)
7.5 India Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020)
7.7 Australia Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Therapeutic Cancer Vaccines Sales, Revenue and Market Share by Country
8.1.1 South America Therapeutic Cancer Vaccines Sales and Market Share by Country (2015-2020)
8.1.2 South America Therapeutic Cancer Vaccines Revenue and Market Share by Country (2015-2020)
8.2 Brazil Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020)
8.3 Argentina Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Therapeutic Cancer Vaccines Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Therapeutic Cancer Vaccines Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Therapeutic Cancer Vaccines Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020)
9.3 Turkey Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020)
9.4 Egypt Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020)
9.5 South Africa Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Therapeutic Cancer Vaccines Sales and Market Share by Type (2015-2020)
10.2 Global Therapeutic Cancer Vaccines Revenue and Market Share by Type (2015-2020)
10.3 Global Therapeutic Cancer Vaccines Price by Type (2015-2020)
11 Global Therapeutic Cancer Vaccines Market Segment by Application
11.1 Global Therapeutic Cancer Vaccines Sales Market Share by Application (2015-2020)
11.2 Global Therapeutic Cancer Vaccines Revenue Market Share by Application (2015-2020)
11.3 Global Therapeutic Cancer Vaccines Price by Application (2015-2020)
12 Market Forecast
12.1 Global Therapeutic Cancer Vaccines Sales, Revenue and Growth Rate (2021-2025)
12.2 Therapeutic Cancer Vaccines Market Forecast by Regions (2021-2025)
12.2.1 North America Therapeutic Cancer Vaccines Market Forecast (2021-2025)
12.2.2 Europe Therapeutic Cancer Vaccines Market Forecast (2021-2025)
12.2.3 Asia-Pacific Therapeutic Cancer Vaccines Market Forecast (2021-2025)
12.2.4 South America Therapeutic Cancer Vaccines Market Forecast (2021-2025)
12.2.5 Middle East & Africa Therapeutic Cancer Vaccines Market Forecast (2021-2025)
12.3 Therapeutic Cancer Vaccines Market Forecast by Type (2021-2025)
12.3.1 Global Therapeutic Cancer Vaccines Sales Forecast by Type (2021-2025)
12.3.2 Global Therapeutic Cancer Vaccines Market Share Forecast by Type (2021-2025)
12.4 Therapeutic Cancer Vaccines Market Forecast by Application (2021-2025)
12.4.1 Global Therapeutic Cancer Vaccines Sales Forecast by Application (2021-2025)
12.4.2 Global Therapeutic Cancer Vaccines Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables
Table 1. Global Therapeutic Cancer Vaccines Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Therapeutic Cancer Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Therapeutic Cancer Vaccines Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Therapeutic Cancer Vaccines Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Antigenics Basic Information, Manufacturing Base and Competitors
Table 9. Antigenics Therapeutic Cancer Vaccines Major Business
Table 10. Antigenics Therapeutic Cancer Vaccines Total Revenue (USD Million) (2018-2019)
Table 11. Antigenics SWOT Analysis
Table 12. Antigenics Therapeutic Cancer Vaccines Product and Services
Table 13. Antigenics Therapeutic Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Moderna Basic Information, Manufacturing Base and Competitors
Table 15. Moderna Therapeutic Cancer Vaccines Major Business
Table 16. Moderna Therapeutic Cancer Vaccines Total Revenue (USD Million) (2018-2019)
Table 17. Moderna SWOT Analysis
Table 18. Moderna Therapeutic Cancer Vaccines Product and Services
Table 19. Moderna Therapeutic Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Bayer Basic Information, Manufacturing Base and Competitors
Table 21. Bayer Therapeutic Cancer Vaccines Major Business
Table 22. Bayer Therapeutic Cancer Vaccines Total Revenue (USD Million) (2018-2019)
Table 23. Bayer SWOT Analysis
Table 24. Bayer Therapeutic Cancer Vaccines Product and Services
Table 25. Bayer Therapeutic Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Asterias Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 27. Asterias Biotherapeutics Therapeutic Cancer Vaccines Major Business
Table 28. Asterias Biotherapeutics Therapeutic Cancer Vaccines Total Revenue (USD Million) (2018-2019)
Table 29. Asterias Biotherapeutics SWOT Analysis
Table 30. Asterias Biotherapeutics Therapeutic Cancer Vaccines Product and Services
Table 31. Asterias Biotherapeutics Therapeutic Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Merck Basic Information, Manufacturing Base and Competitors
Table 33. Merck Therapeutic Cancer Vaccines Major Business
Table 34. Merck Therapeutic Cancer Vaccines Total Revenue (USD Million) (2018-2019)
Table 35. Merck SWOT Analysis
Table 36. Merck Therapeutic Cancer Vaccines Product and Services
Table 37. Merck Therapeutic Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Avax Technologies Basic Information, Manufacturing Base and Competitors
Table 39. Avax Technologies Therapeutic Cancer Vaccines Major Business
Table 40. Avax Technologies Therapeutic Cancer Vaccines Total Revenue (USD Million) (2018-2019)
Table 41. Avax Technologies SWOT Analysis
Table 42. Avax Technologies Therapeutic Cancer Vaccines Product and Services
Table 43. Avax Technologies Therapeutic Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. VAXIMM Basic Information, Manufacturing Base and Competitors
Table 45. VAXIMM Therapeutic Cancer Vaccines Major Business
Table 46. VAXIMM Therapeutic Cancer Vaccines Total Revenue (USD Million) (2018-2019)
Table 47. VAXIMM SWOT Analysis
Table 48. VAXIMM Therapeutic Cancer Vaccines Product and Services
Table 49. VAXIMM Therapeutic Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Mayo Clinic Basic Information, Manufacturing Base and Competitors
Table 51. Mayo Clinic Therapeutic Cancer Vaccines Major Business
Table 52. Mayo Clinic Therapeutic Cancer Vaccines Total Revenue (USD Million) (2018-2019)
Table 53. Mayo Clinic SWOT Analysis
Table 54. Mayo Clinic Therapeutic Cancer Vaccines Product and Services
Table 55. Mayo Clinic Therapeutic Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 57. GlaxoSmithKline Therapeutic Cancer Vaccines Major Business
Table 58. GlaxoSmithKline Therapeutic Cancer Vaccines Total Revenue (USD Million) (2018-2019)
Table 59. GlaxoSmithKline SWOT Analysis
Table 60. GlaxoSmithKline Therapeutic Cancer Vaccines Product and Services
Table 61. GlaxoSmithKline Therapeutic Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Northwest Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 63. Northwest Biotherapeutics Therapeutic Cancer Vaccines Major Business
Table 64. Northwest Biotherapeutics Therapeutic Cancer Vaccines Total Revenue (USD Million) (2018-2019)
Table 65. Northwest Biotherapeutics SWOT Analysis
Table 66. Northwest Biotherapeutics Therapeutic Cancer Vaccines Product and Services
Table 67. Northwest Biotherapeutics Therapeutic Cancer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Global Therapeutic Cancer Vaccines Sales by Manufacturer (2018-2019) (K Units)
Table 69. Global Therapeutic Cancer Vaccines Revenue by Manufacturer (2018-2019) (USD Million)
Table 70. Global Therapeutic Cancer Vaccines Sales by Regions (2015-2020) (K Units)
Table 71. Global Therapeutic Cancer Vaccines Sales Market Share by Regions (2015-2020)
Table 72. Global Therapeutic Cancer Vaccines Revenue by Regions (2015-2020) (USD Million)
Table 73. North America Therapeutic Cancer Vaccines Sales by Countries (2015-2020) (K Units)
Table 74. North America Therapeutic Cancer Vaccines Sales Market Share by Countries (2015-2020)
Table 75. North America Therapeutic Cancer Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 76. North America Therapeutic Cancer Vaccines Revenue Market Share by Countries (2015-2020)
Table 77. Europe Therapeutic Cancer Vaccines Sales by Countries (2015-2020) (K Units)
Table 78. Europe Therapeutic Cancer Vaccines Sales Market Share by Countries (2015-2020)
Table 79. Europe Therapeutic Cancer Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 80. Asia-Pacific Therapeutic Cancer Vaccines Sales by Regions (2015-2020) (K Units)
Table 81. Asia-Pacific Therapeutic Cancer Vaccines Sales Market Share by Regions (2015-2020)
Table 82. Asia-Pacific Therapeutic Cancer Vaccines Revenue by Regions (2015-2020) (USD Million)
Table 83. South America Therapeutic Cancer Vaccines Sales by Countries (2015-2020) (K Units)
Table 84. South America Therapeutic Cancer Vaccines Sales Market Share by Countries (2015-2020)
Table 85. South America Therapeutic Cancer Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 86. South America Therapeutic Cancer Vaccines Revenue Market Share by Countries (2015-2020)
Table 87. Middle East & Africa Therapeutic Cancer Vaccines Sales by Countries (2015-2020) (K Units)
Table 88. Middle East & Africa Therapeutic Cancer Vaccines Sales Market Share by Countries (2015-2020)
Table 89. Middle East & Africa Therapeutic Cancer Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 90. Middle East & Africa Therapeutic Cancer Vaccines Revenue Market Share by Countries (2015-2020)
Table 91. Global Therapeutic Cancer Vaccines Sales by Type (2015-2020) (K Units)
Table 92. Global Therapeutic Cancer Vaccines Sales Share by Type (2015-2020)
Table 93. Global Therapeutic Cancer Vaccines Revenue by Type (2015-2020) (USD Million)
Table 94. Global Therapeutic Cancer Vaccines Revenue Share by Type (2015-2020)
Table 95. Global Therapeutic Cancer Vaccines Sales by Application (2015-2020) (K Units)
Table 96. Global Therapeutic Cancer Vaccines Sales Share by Application (2015-2020)
Table 97. Global Therapeutic Cancer Vaccines Sales Forecast by Regions (2021-2025) (K Units)
Table 98. Global Therapeutic Cancer Vaccines Market Share Forecast by Regions (2021-2025)
Table 99. Global Therapeutic Cancer Vaccines Sales Forecast by Type (2021-2025) (K Units)
Table 100. Global Therapeutic Cancer Vaccines Market Share Forecast by Type (2021-2025)
Table 101. Global Therapeutic Cancer Vaccines Sales Forecast by Application (2021-2025)
Table 102. Global Therapeutic Cancer Vaccines Market Share Forecast by Application (2021-2025)
Table 103. Direct Channel Pros & Cons
Table 104. Indirect Channel Pros & Cons
Table 105. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Therapeutic Cancer Vaccines Picture
Figure 2. Global Sales Market Share of Therapeutic Cancer Vaccines by Type in 2019
Figure 3. Whole Cell Vaccine Picture
Figure 4. Antigen Vaccine Picture
Figure 5. Non-specific and Cytokine Strategies Picture
Figure 6. Others Picture
Figure 7. Therapeutic Cancer Vaccines Sales Market Share by Application in 2018
Figure 8. Bladder Cancer Picture
Figure 9. Brain Tumors Picture
Figure 10. Breast Cancer Picture
Figure 11. Lung Cancer Picture
Figure 12. Prostate Cancer Picture
Figure 13. Cervical Cancer Picture
Figure 14. Others Picture
Figure 15. Global Therapeutic Cancer Vaccines Market Status and Outlook (2015-2025) (USD Million)
Figure 16. United States Therapeutic Cancer Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Canada Therapeutic Cancer Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Mexico Therapeutic Cancer Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Germany Therapeutic Cancer Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 20. France Therapeutic Cancer Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 21. UK Therapeutic Cancer Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Russia Therapeutic Cancer Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Italy Therapeutic Cancer Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 24. China Therapeutic Cancer Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Japan Therapeutic Cancer Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Korea Therapeutic Cancer Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 27. India Therapeutic Cancer Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Southeast Asia Therapeutic Cancer Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Australia Therapeutic Cancer Vaccines Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 30. Brazil Therapeutic Cancer Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Egypt Therapeutic Cancer Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Saudi Arabia Therapeutic Cancer Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 33. South Africa Therapeutic Cancer Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Turkey Therapeutic Cancer Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Global Therapeutic Cancer Vaccines Sales Market Share by Manufacturer in 2019
Figure 36. Global Therapeutic Cancer Vaccines Revenue Market Share by Manufacturer in 2019
Figure 37. Top 3 Therapeutic Cancer Vaccines Manufacturer (Revenue) Market Share in 2019
Figure 38. Top 6 Therapeutic Cancer Vaccines Manufacturer (Revenue) Market Share in 2019
Figure 39. Key Manufacturer Market Share Trend
Figure 40. Global Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 41. Global Therapeutic Cancer Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 42. Global Therapeutic Cancer Vaccines Revenue Market Share by Regions (2015-2020)
Figure 43. Global Therapeutic Cancer Vaccines Revenue Market Share by Regions in 2018
Figure 44. North America Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020)
Figure 45. Europe Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020)
Figure 47. South America Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020)
Figure 48. Middle East & Africa Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020)
Figure 49. North America Therapeutic Cancer Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 50. North America Therapeutic Cancer Vaccines Sales Market Share by Countries (2015-2020)
Figure 51. North America Therapeutic Cancer Vaccines Sales Market Share by Countries in 2018
Figure 52. North America Therapeutic Cancer Vaccines Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 53. North America Therapeutic Cancer Vaccines Revenue Market Share by Countries in 2018
Figure 54. United States Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 55. Canada Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Mexico Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Europe Therapeutic Cancer Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 58. Europe Therapeutic Cancer Vaccines Revenue Market Share by Countries (2015-2020)
Figure 59. Europe Therapeutic Cancer Vaccines Revenue Market Share by Countries in 2019
Figure 60. Germany Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 61. UK Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 62. France Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Russia Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Italy Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Asia-Pacific Therapeutic Cancer Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 66. Asia-Pacific Therapeutic Cancer Vaccines Sales Market Share by Regions 2019
Figure 67. Asia-Pacific Therapeutic Cancer Vaccines Revenue Market Share by Regions 2019
Figure 68. China Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Japan Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Korea Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 71. India Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Southeast Asia Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 73. South America Therapeutic Cancer Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. South America Therapeutic Cancer Vaccines Sales Market Share by Countries in 2019
Figure 75. South America Therapeutic Cancer Vaccines Revenue Market Share by Countries in 2019
Figure 76. Brazil Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Argentina Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Middle East and Africa Therapeutic Cancer Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 79. Middle East and Africa Therapeutic Cancer Vaccines Sales Market Share by Countries in 2019
Figure 80. Middle East and Africa Therapeutic Cancer Vaccines Revenue Market Share by Countries (2015-2020)
Figure 81. Middle East and Africa Therapeutic Cancer Vaccines Revenue Market Share by Countries in 2019
Figure 82. Saudi Arabia Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Egypt Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 84. Turkey Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 85. South Africa Therapeutic Cancer Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 86. Global Therapeutic Cancer Vaccines Sales and Growth Rate (2021-2025) (K Units)
Figure 87. Global Therapeutic Cancer Vaccines Revenue and Growth Rate (2021-2025) (USD Million)
Figure 88. North America Sales Therapeutic Cancer Vaccines Market Forecast (2021-2025) (K Units)
Figure 89. Europe Sales Therapeutic Cancer Vaccines Market Forecast (2021-2025) (K Units)
Figure 90. Asia-Pacific Sales Therapeutic Cancer Vaccines Market Forecast (2021-2025) (K Units)
Figure 91. South America Sales Therapeutic Cancer Vaccines Market Forecast (2021-2025) (K Units)
Figure 92. Middle East & Africa Sales Therapeutic Cancer Vaccines Market Forecast (2021-2025) (K Units)
Figure 93. Sales Channel: Direct Channel vs Indirect Channel